HOLLISTON, Mass., — Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that its Board of Directors has hired Jeffrey A. Duchemin, a veteran life science executive, as Harvard Bioscience’s Chief Executive Officer. David Green, who has served […]
ATCC, the premier global biological materials resource and standards organization, announces material deposit agreements with over 30 leading public and private institutions. These institutions will have the option to participate in the new Biomaterial Contributor Network (BCN), and make important research materials available to the research community. ATCC will coordinate with Technology Transfer Offices at […]
ANVERS, Mass.– Cell Signaling Technology, Inc. (CST) of Danvers, MA, announced today that it has introduced a highly specific HER3 rabbit monoclonal antibody (mAb), an important addition for researchers studying HER2-mediated breast, lung and ovarian tumors. Although HER2 has been intensively studied for over 20 years, only recently has it come to light that HER3 […]
Medford, – Hepregen Corporation, developer of next generation HepatoPacTM and HepatoMuneTM products, announced today the commercial launch of the Company’s first applicationoriented Human HepatoPacTM Kit designed specifically for use in metabolite identification and profiling. The DMPK Kit, first of its kind, was developed over a 5-year period with significant input from Hepregen’s pharmaceutical company customers […]
PISCATAWAY, N.J.– RUCDR Infinite Biologics, the world’s largest university-based biorepository, has added NuGEN Technologies to its group of technology sponsors. A unit of Rutgers, The State University of New Jersey, RUCDR Infinite Biologics currently stores more than 12 million biosamples. Dr. Andy Brooks, chief operating officer of RUCDR Infinite Biologics, said: “The RUCDR corporate sponsorship […]
Vienna, Europe, — and CeMM, the Center for Molecular Medicine of the Austrian Academy of Sciences, today announced that they are making available their large collection of human cell lines that are deficient for single genes, which they have been building over the past three years as part of a public The partnership, through Haplogen, […]
The company has established a competitive program to provide financial assistance to students who are pursuing an undergraduate degree or equivalent in a STEM field (science, technology, engineering and math) at five premier institutions globally: Massachusetts Institute of Technology; University of Wisconsin-Madison; University of California-Berkeley; Imperial College London and Fudan University in Shanghai. These schools […]
CAMBRIDGE, England, — Once thought to be just part of the cells waste disposal system, it is now clear that exosomes also act as microscopic delivery bags, protecting RNA and protein contents that can then be transported in the blood, influencing the activity of distant cells. Exosomes may be useful in Cancer diagnostics and for […]
AMSBIO has announced that it has reached agreement with Sanguine BioSciences, abiotechnology company enabling personalized medicine research, to distribute and support its products and services throughout Europe. Commenting on the new agreement Phillip Pridham-Field of AMSBIO said “Sanguine’s approach to biospecimen collection and their high patient retention allow researchers to collect the data they need […]
ALAMEDA, Calif.– BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced the expansion of its senior management team with the appointment of Lesley Stolz, Ph.D. as Executive Vice President, Corporate Development. Dr. Stolz has more than 18 years of life science industry experience […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
